期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 20, 期 34, 页码 12102-12117出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v20.i34.12102
关键词
Crohn's disease; Intestinal microbiota; Dysbiosis; Adherent-invasive Escherichia coli; Probiotics; Antibiotics; Fecal microbiota transplantation
资金
- Ministere de la Recherche et de la Technologie
- Inserm [UMR1071]
- INRA [USC-2018]
- Association Francois Aupetit
- European Union
Important advances during the last decade have been made in understanding the complex etiopathogenesis of Crohn's disease (CD). While many gaps in our knowledge still exist, it has been suggested that the etiology of CD is multifactorial including genetic, environmental and infectious factors. The most widely accepted theory states that CD is caused by an aggressive immune response to infectious agents in genetically predisposed individuals. The rise of genome-wide association studies allowed the identification of loci and genetic variants in several components of host innate and adaptive immune responses to microorganisms in the gut, highlighting an implication of intestinal microbiota in CD etiology. Moreover, numerous independent studies reported a dysbiosis, i.e., a modification of intestinal microbiota composition, with an imbalance between the abundance of beneficial and harmful bacteria. Although microorganisms including viruses, yeasts, fungi and bacteria have been postulated as potential CD pathogens, based on epidemiological, clinicopathological, genetic and experimental evidence, their precise role in this disease is not clearly defined. This review summarizes the current knowledge of the infectious agents associated with an increased risk of developing CD. Therapeutic approaches to modulate the intestinal dysbiosis and to target the putative CD-associated pathogens, as well as their potential mechanisms of action are also discussed. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据